Document is current
Any future updates will be listed below
-
Authors
Pilla Reddy, Venkatesh https://orcid.org/0000-0002-7786-4371
Fretland, Adrian J.
Zhou, Diansong
Sharma, Shringi
Chen, Buyun
Vishwanathan, Karthick
McGinnity, Dermot F.
Xu, Yan
Ware, Joseph A.
-
Funding
Funding for this research was provided by:
Acerta Pharma, a member of the AstraZeneca Group
- License Information
-
More Information
Article History
Received: 8 October 2020
Accepted: 18 May 2021
First Online: 2 June 2021
Declarations
:
: VP Reddy is a current employee and stock shareholder of AstraZeneca. AJ Fretland was an employee of AstraZeneca at the time of this study. D Zhou is a current employee of AstraZeneca. S Sharma is a current employee of Acerta Pharma (a member of the AstraZeneca Group) and stock shareholder of AstraZeneca. B Chen is a current employee of Acerta Pharma (a member of the AstraZeneca Group). K Vishwanathan is a current employee and stock shareholder of AstraZeneca. DF McGinnity is a current employee of AstraZeneca. Y Zu is a current employee of Acerta Pharma (a member of the AstraZeneca Group). JA Ware was an employee of Acerta Pharma (a member of the AstraZeneca Group) at the time of this study and is a stock shareholder in AstraZeneca.
: Not applicable.
: Not applicable.
: Not applicable for this physiology-based pharmacokinetic model.
